CN102908458A - 生发黑发的中药制剂及其生产方法 - Google Patents
生发黑发的中药制剂及其生产方法 Download PDFInfo
- Publication number
- CN102908458A CN102908458A CN2012104531814A CN201210453181A CN102908458A CN 102908458 A CN102908458 A CN 102908458A CN 2012104531814 A CN2012104531814 A CN 2012104531814A CN 201210453181 A CN201210453181 A CN 201210453181A CN 102908458 A CN102908458 A CN 102908458A
- Authority
- CN
- China
- Prior art keywords
- liquid
- gets
- ethanol
- hair
- heating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 47
- 230000001737 promoting effect Effects 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 132
- 239000007788 liquid Substances 0.000 claims description 90
- 238000010438 heat treatment Methods 0.000 claims description 36
- 230000037308 hair color Effects 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 21
- 239000008187 granular material Substances 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- 238000011084 recovery Methods 0.000 claims description 12
- 238000004064 recycling Methods 0.000 claims description 12
- 239000003643 water by type Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 9
- 235000008504 concentrate Nutrition 0.000 claims description 9
- 239000013067 intermediate product Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 6
- -1 spray drying Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000005030 aluminium foil Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 20
- 210000003780 hair follicle Anatomy 0.000 abstract description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 7
- 240000006063 Averrhoa carambola Species 0.000 abstract description 6
- 235000010082 Averrhoa carambola Nutrition 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 240000008027 Akebia quinata Species 0.000 abstract description 2
- 235000007756 Akebia quinata Nutrition 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 241000893536 Epimedium Species 0.000 abstract description 2
- 241001289529 Fallopia multiflora Species 0.000 abstract description 2
- 235000018905 epimedium Nutrition 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000950640 Calcarius Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 238000001668 nucleic acid synthesis Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 24
- 201000004384 Alopecia Diseases 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 22
- 231100000360 alopecia Toxicity 0.000 description 20
- 206010049865 Achromotrichia acquired Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 241000220645 Leonotis nepetifolia Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000004631 alopecia areata Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000003659 hair regrowth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 206010001766 Alopecia totalis Diseases 0.000 description 2
- 206010001767 Alopecia universalis Diseases 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 240000004274 Sarcandra glabra Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 208000032775 alopecia universalis congenita Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000002333 glycines Chemical class 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000722818 Aralia Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 240000005697 Averrhoa bilimbi Species 0.000 description 1
- 235000015894 Averrhoa bilimbi Nutrition 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016100 Faeces discoloured Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000208165 Oxalidaceae Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000010842 Sarcandra glabra Nutrition 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 240000005872 Shuteria involucrata var. villosa Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 241001619444 Wolfiporia cocos Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种生发黑发的中药制剂,其特征在于:该中药制剂是由以下中药原料:阳桃、九节风、淫羊霍、何首乌、甘草、胶股蓝、茯苓、红花和枸杞制成;本发明具有增强组织功能,增高人体免疫力,血液流畅,改善微循,促进营养和微量元素吸收、提高核酸合成串,使毛母细胞分裂、代谢旺盛、加快黑色素生成、促进白发转黑,同时具有抗菌消炎作用,使毛囊炎症消失,脱发停止,长出新发,毛发乌黑亮浑。
Description
技术领域
本发明涉及一种中药制剂,尤其是一种生发黑发的中药制剂,以及该中药制剂的生产方法。
背景技术
人到中年以后,随着年龄增长,体内器官功能降低,新陈代谢表沮,促使人体衰老。随着经济的发展,现代生活节奏的加快和生活压力的剧增,因为免疫功能紊乱、耪神受到刺激或茶种疾病的诱发,使毛囊和毛母细胞萤缩、出现白发、脱发、笼头等头发疾病的发病率也越来越高,给现代人的生活带来了越来越多地困扰。脱发不仅影响美观,还会使患者的心理产生自卑、抑郁等不良情绪,从而使正常的工作、生活和社交活动都受到影响。脱发按其症状可分为脂溢性脱发、早发性脱发、斑秃、全秃、普秃和产后脱发等,目前还没有特效药物能够治疗脱发。
中医认为脱发大多数是由于身体机能失调造成的,其病机是由于精神和营养两方面原因。忧伤郁闷会导致肝肾心脾俱伤,使头发失去营养而脱落;或者由于血癌血虚实头皮毛根供血不足,使毛发缺乏营养,从而脱发。
1、中国专利,申请号:200710044690.0 申请日:2007.08.08 名称:一种生发、黑发保健品及其制备方法 申请(专利权)人:徐翠琴 地址:上海市普陀区岚皋路石岚三村72号301室 发明 (设计)人:徐翠琴 摘要 该发明公开了一种生发、黑发保健品及其制备方法,它由包括黑芝麻、白芝麻、榛子、黑米、黑豆、花豆、黄豆在内的原料经洗捡、烘干、炒熟、粉碎、筛选混合,再经消毒、杀菌后与适量蜂蜜调配而成;原料重量百分比:黑芝麻30~40%、白芝麻8~10%、榛子9~12%、黑米10~15%、黑豆8~15%、花豆5~10%、黄豆6~10%。对粉末状成品分袋包装或制成胶囊,服用前再用蜂蜜调配或冲服;亦可预先放入蜂蜜均匀搅拌后制成糖果式块状或球状,便于外出携带服用。所采用的配料均为纯天然食品,按照科学比例配制,长期服用无任何副作用,经一段时间的服用即可解决脱发、白发问题,对于少白头发、花白头发均具有良好效果。
2、中国专利,申请号:200810102112.2 申请日:2008.03.18 名称:一种治疗脱发病和生发黑发的中药组合物及其制法 申请(专利权)人:北京中科雍和医药技术有限公司 地址:100027北京市东城区安定门东大街28号雍和大厦东楼1单元508 发明(设计)人:张云峰;鄢良;张韬 摘要:该发明公开了一种治疗脱发病和生发黑发的中药组合物及其制备方法,它主要由制首乌、当归、侧柏叶、白芷、沙棘、枸杞、肉桂、山药、红花、人参、生姜和桑椹制成。本发明的中药组合物具有滋肝补肾、活血化瘀、补气补血、祛风除湿、化瘀生新和止脱生发的功效,能标本兼治,对脂溢性脱发、早发性脱发、斑秃、全秃、普秃和产后脱发等均有很好的治疗效果。其配方简单,生产简便,患者服用方便,疗效显著,具有广泛的应用价值。
3、中国专利,申请号:201210220961.4 申请日: 2012.06.29 名称:一种乌发生发的中药组合物及其制备方法和应用 申请(专利权)人:赵连盛 地址:甘肃省兰州市七里河区西站东路50号503 发明(设计)人:赵连盛 摘要:本发明公开了一种乌发生发的中药组合物,包括有以下重量份的各原料药:女贞子10-15份、当归10-15份、白芍10-15份和旱莲草15-20份,同时提供了其制备方法和用途。本发明的有益效果为:本发明提供的中药组合物,由于完全是中药制成,其毒副作用相较于以往药物小,女贞子滋肝补肾,乌须黑发、生发,当归养血、活血、补血,发为血之余,因而有生发作用,白芍养血柔肝,与当归同用,加强当归补血生发作用,四味中药合用共凑乌须、生发作用,与同类101产品相比,疗效确切、快捷,如斑秃,服用生发丸一个月即可生出新发来,新生出来的新发在5mm至10mm绒发来,脱发服用生发丸一个月可占95%脱发患者,如斑秃、脱发,均可恢复,并且面容荣润,白里透出一种红润来。
从上述文献看,从临床效果看各有千秋。未发现相同配方类似的相关文献,因此研发一种新的配方简单,生产简便,患者服用方便,疗效显著,具有增强府留组织功能,增高人体免疫力,血液流畅,改善微循,促进营养和微量元素吸收、提高核酸合成串,使毛母细胞分裂、代谢旺盛、加快黑色素生成、促进白发转黑,同时具有抗菌消炎作用,使毛囊炎症消失,脱发停止,长出新发,毛发乌黑亮浑的生发黑发的中药制剂是有必要的。
发明内容
本发明的目的提供一种配方简单,生产简便,患者服用方便,疗效显著,具有增强府留组织功能,增高人体免疫力,血液流畅,改善微循,促进营养和微量元素吸收、提高核酸合成串,使毛母细胞分裂、代谢旺盛、加快黑色素生成、促进白发转黑;同时具有抗苗消炎作用,使毛囊炎症消失,脱发停止,长出新发,毛发乌黑亮浑的生发黑发的中药制剂及其生产方法。
本发明是这样实现的:
本发明生发黑发的中药制剂,是由以下重量份数的中药原料制成的:
阳 桃 10-30;
九节风 10-30;
淫羊藿 10-30;
何首乌 10-30;
甘 草 5-20;
胶股蓝 10-30;
茯 苓 10-30;
红 花 5-20;
枸 杞 10-30。
本发明由阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花、枸杞组成,具有补肾壮阳、强筋壮骨、益气强心、祛风除湿、益精血,乌须发,强筋骨,降血脂,抗衰老、养肝明目,补血安神,生津止渴,润肺止咳的功效,从而达到生发黑发的目的。
以上所述的生发黑发的中药制剂的中药配方的各药有效成份分析:
阳 桃:【别名】:三廉、杨桃、五敛子、五棱子、山敛、三敛子、羊桃、泽挑、五敛、酸五棱、三棱子、木踏子、风鼓、鬼桃、酸桃、蜜桃杨、梅桃。【英文名】:Fruit of Carambola 【拉丁名】: Averrhoa carambola L. 【科属分类】:酢浆草科【性味归经】:性寒,味甘酸;入肺、心、小肠经。【功效】:清热生津,利水解毒,下气和中,利尿通淋。【主治】:风热咳嗽;咽痛;烦渴;石淋;口糜;牙痛;疟母;小便不通等病症。
九节风:【别名】九节茶、九节风、接骨莲,肿节风,接骨兰。【拉丁文】Herba Sarcandrae 九节风(英)Glabrous Sarcandra Herb ,为金栗兰科植物草珊瑚Sarcandra glabra (Thunb.) Nakai的全株。生于山沟、溪谷林阴湿地,分布于华东、中南、西南。夏、秋季采挖,除去杂质,晒干。性微温,味苦、辛。抗菌消炎,祛风通络,活血散结。用于肺炎、阑尾炎、蜂窝组织炎、风湿痹痛、跌打损伤、肿瘤。
淫羊藿:【别名】羊藿叶,仙灵脾,三枝九叶草,刚前,干鸡筋,铁菱角 ,【拉丁文学名】HERBA EPIMEDII,淫羊藿性味辛,甘,温,具有补肾壮阳、强筋壮骨、益气强心、祛风除湿的功效,适用于治疗阳痿、遗精、早泄、性机能衰退、月经不调、更年期综合征、高血压、风湿痛、半身不遂、四肢麻木、膝软无力等症。现代医学研究认为,淫羊藿有促进精液分泌的作用;有持久的降血压作用;有抗肺炎链球菌、结核杆菌、金黄色葡萄球菌的作用。
何首乌:【别名】首乌、赤首乌、铁秤砣、红内消和夜交藤,【拉丁文学名】Polygonum multiflorum Thunb.【英文名】 RADIX POLYGONI MULTIFLORI,科名:蓼科Polygonaceae 、蓼属,多年生草本,无毛。制何首乌是目前唯一被证明具有抗衰老作用的传统要药,性苦、甘、涩、温,归肝、心、肾经具有补肝肾,益精血,乌须发,强筋骨,降血脂,抗衰老的功效。用于血虚萎黄,眩晕耳鸣,须发早白,腰膝酸软,肢体麻木,崩漏带下,久病体虚,高血脂症。
甘 草:【别称】甜草根、红甘草、粉甘草,【拉丁文学名】Glycyrrhizae,甘草是一种补益中草药,甘草性平,味甘,归十二经。有解毒、祛痰、止痛、解痉以至抗癌等药理作用【功效与作用】:益气补中;缓急止痛;润肺止咳;泻火解毒;调和诸药。主倦怠食少;肌瘦面黄;心悸气短;腹痛便溏;四肢挛急疼痛;脏躁;咳嗽气喘;咽喉肿痛;痈疮肿痛;小儿胎毒;及药物、食物中毒。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性;在中医上,甘草补脾益气,止咳润肺,缓急解毒,调和百药。
胶股蓝:【又名】乌七叶胆、七叶胆、五叶参、七叶参、小苦药等。绞股蓝为多年生宿根植物,广泛分布于亚热带和北亚热带地区。性寒、味甘,有益气,安神,降血压之功效,民间称其为“神奇”的“不老长寿药草”,“星火计划”中将其列为“名贵中药材”之首位。【拉丁文学名】Fiveleaf Gynostemma Herb ,【性味与归经】① 寒;苦;归肺、脾、肾经。② 苦、微甘,凉。归肺、脾、肾经。【功效】补五脏,强身体,却病抗癌。适用于一切虚症,尤其是体弱多病者。用于治疗高血脂,高血压,高血糖,尤其是对高血脂有疗效显著,是其他药食难以替代的。绞股蓝还有降血脂、降血压、降血糖、镇静、催眠、抗紧张、抗溃疡、抗疲劳、延长细胞寿命以及增进食欲,增强抵抗力,通畅大便,平喘止咳,消痔、减肥、治疗虚症、抑制胆结石形成、防治糖皮质激素副作用、抗衰老与治疗老年性白发、狐臭、美润皮肤等多种功效。
茯 苓:【别称】玉灵、茯灵、万灵桂、茯菟,茯菟(《本经》),茯灵(《史记》),茯蕶(《广雅》),伏苓、伏菟(《唐本草》),松腴(《记事珠》),绛晨伏胎(《酉阳杂俎》),云苓(《滇海虞衡志》),茯兔(《纲目》),松薯、松木薯,松苓(《广西中药志》)。是拟层孔菌科真菌茯苓的干燥菌核,常寄生在松树根上,形如甘薯,球状,外皮淡棕色或黑褐色,内部粉色或白色,精制后称为白茯苓或者云苓。【拉丁学名】Wolfiporia cocos【性味功能】土茯苓味甘、淡,性平。有清热,除湿,解毒,利关节的功能。【主治用法】用于关节酸痛,尿路感染,白带,湿热疮毒,梅毒,红皮病,急性菌痢,瘰疬,并用于治疗钩端螺旋体病。
红 花:又称草红花、草红、刺红花、杜红花、金红花。双子叶植物,菊科,干燥的管状花,长约1.5厘米,橙红色,花管狭细,先端5裂,裂片狭线形,长5~7毫米,雄蕊5枚,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。【中药材学名】Flos Carthami,(英)Safflower 红花味辛、性温,归心、肝经 气香行散,入血分具有活血通经,祛瘀止痛的功效;主治痛经,经闭,产后血晕,瘀滞腹痛,胸痹心痛,血积,跌打瘀肿,关节疼痛,中风瘫痪,斑疹紫暗。
枸 杞:【别名】枸杞菜、红珠仔刺、牛右力、狗牙子,是茄科枸杞属的多分枝灌木植物,【英文名】Barbary Wolfberry Fruit ,【拉丁文】Lycium chinense,具有补肾益精,养肝明目,补血安神,生津止渴,润肺止咳。治肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精。
以上所述的生发黑发的中药制剂为口服液、颗粒剂、胶囊、片剂或其它可药学的剂型。
以上所述的生发黑发的中药制剂已经在临床生发黑发的项目中初步试用,反映良好,无明显毒副作用。
按相关剂型的常规制剂工艺,加入适量辅料制成相应的剂型,上述中药制剂还可以制成口服液、颗粒剂、胶囊、片剂或其它可药学的剂型。
将上述各组份制成本发明生发黑发的中药制剂的生产方法:
1、口服液的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液,加入适量糖浆,混匀,灌装,灭菌,得成品口服液,本发明产品命名为:乌尔云口服液。
2、颗粒剂的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,得干膏粉F;
(6)取中间产品干膏粉F与适量辅料混匀,制粒,干燥,分装,得成品颗粒剂,本发明产品命名为:乌尔云颗粒剂。
3、胶囊剂的生产方法:
(1)按重量配比阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品F与适量辅料混匀,制粒,装胶囊,铝箔包装,分装,得成品胶囊剂,本发明产品命名为:乌尔云胶囊。
4、片剂的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品干膏粉F与适量辅粒混合,制粒,压片,包装,得成品片剂,乌尔云片剂。
本发明产品的服用方法:
口服液,每天2至3次,每次10ml;胶囊剂,每天2至3次,每天2粒;颗粒剂,每天2至3次,每次1袋,每袋7克;片剂,每天2至3次,每次2至3片,每片0.3克。
本发明的有益效果是:
1、本发明具有增强府留组织功能,增高人体免疫力,血液流畅,改善微循,促进营养和微量元素吸收、提高核酸合成串,使毛母细胞分裂、代谢旺盛、加快黑色素生成、促进白发转黑。
2、本发明同时具有抗苗消炎作用,使毛囊炎症消失,脱发停止,长出新发,毛发乌黑亮浑。
3、本发明系多种名贵中草药为原料,经过科学组方、精制而成的无毒剧作用。
4、本发明配方简单,生产简便,患者服用方便,疗效显著。
具体实施方式
实施例1:
口服液的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液,加入适量糖浆,混匀,灌装,灭菌,得成品口服液,本发明产品命名为:乌尔云口服液。
实施例2:
颗粒剂的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,得干膏粉F;
(6)取中间产品干膏粉F与适量辅料混匀,制粒,干燥,分装,得成品颗粒剂,本发明产品命名为:乌尔云颗粒剂。
实施例3:
胶囊剂的生产方法:
(1)按重量配比阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品F与适量辅料混匀,制粒,装胶囊,铝箔包装,分装,得成品胶囊剂,本发明产品命名为:乌尔云胶囊。
实施例4:
片剂的生产方法:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品干膏粉F与适量辅粒混合,制粒,压片,包装,得成品片剂,乌尔云片剂。
病例1:
黄先生,男,64岁,地址广西斯医科大附院,诊断:头发脱落、稀疏、白发。症状体征(临床表现):十年前头发脱落、稀疏,头发变白达到70%以上。多年来经多方治疗不见效,且越来越严重。2004年9月服用本发明一个疗程后,开始见效。继续服用2个疗程(每个疗程30天)后头发不脱落,生发;白发也慢慢转黑,转黑发达80%,胡须也变黑、眉毛也长,发变黑变粗。另外服药三个疗程体能气质有很大改善。
病例2:
方先生,男,69岁,地址广西医科大附院,2004年就诊,症状体征(临床表现):十多年前头发开始变白且断断续续脱发稀疏。曾多种药物口服和外用都不见效。服用本发明2个月后白发变黑,身体好精神好,头昏腰累等症状已消失。
病例3:
陈先生,男,61岁,地址广西南宁制药,高级工程师,2003年8月就诊,诊断:秃头、白发。症状体征(临床表现):秃头、白发。曾自己开中草药治疗,秃头、白发都不见效。2003年8月开始服用本发明两个疗程后,白发变成黑发达80%,秃头开始长出细小黑发,断续服用2个疗程秃头也基本生发满头。
一、临床试验资料
本发明的急性毒性试验报告鉴定
1 摘要
对乌尔云口服液进行了小鼠口服途径的急性毒性试验,结果小鼠24小时内灌胃给予乌尔云口服液浓缩0.9ml,未见小鼠死亡及其它的毒性反应,表明乌尔云口服液给药无毒性反应。
2 试验目的
观察乌尔云口服液在24小时内多次灌胃给予小鼠所产生的毒性反应情况。
3 受试药物
3.1 名称
乌尔云口服液,由李志海提供。
3.2受试物
为其原液100ml浓缩至22ml。
4 动物
4.1来源、种属、品系
由广西医科大学医学实验动物中心提供,普通级,昆明种小白鼠。
4.2性别
雌雄兼用
4.3体重
20-22g
4.4动物数
20只
4.5饲养条件
室温25-28℃,喂养本校动物中心常规小鼠饲料,饮用自来水。
5 试验方法
5.1给药途径
口服灌胃给药
5.2给药容积
0.3ml/10g/次
5.3 给药次数
在24小时内分3次灌胃给予受试物。
5.4观察时间
观察小鼠给药期间反应及停药后7天内反应情况。
5.5观察指标
观察大鼠在给药期间及停药后7天的活动、食欲、大小便、精神、体重及死亡情况。
6 结果
20只小鼠,给药期间及停药后7天内饮食正常,大便黑色成形,未见精神差、毛松等异常表现及动物死亡。
7 结论
小鼠在24小时内给予乌尔云口服液浓缩液0.9ml/10g(相当原液4.09ml/10g),相当于拟临床用量20ml/60kg的1227倍,末见明显的毒性反应,表明乌尔云口服液口服给药是安全的。
8 参考文献
8.1中华人民共和国卫生部药政管理局 中药新药研究指南(药学药理学 毒理学)第203—204页。
9 试验负责人
杨斌(副教授)
10试验者
杨斌 周丽
11试验日期
2002年4月25日-2002年5月2日
12 原始资料保存处、联系人、电话
广西医科大学药理学教研室
杨斌(0771-5358272)
Claims (6)
1.一种生发黑发的中药制剂,其特征在于:该中药制剂是由以下重量份数的中药原料制成的:
阳 桃 10-30;九节风 10-30;
淫羊藿 10-30;何首乌 10-30;
甘 草 5-20;胶股蓝 10-30;
茯 苓 10-30;红 花 5-20;
枸 杞 10-30。
2.根据权利要求1所述的生发黑发的中药制剂,其特征在于:所述的生发黑发的中药制剂为口服液、颗粒剂、胶囊、片剂或其它可药学的剂型。
3.根据权利要求1和2所述的生发黑发的中药制剂的生产方法,其特征在于:所述的口服液的生产步骤如下:
(1)按重量配比取阳桃、九节风、淫羊藿、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液,加入适量糖浆,混匀,灌装,灭菌,得成品口服液。
4.根据权利要求1和2所述的生发黑发的中药制剂的生产方法,其特征在于:所述的颗粒剂的的生产步骤如下:
(1)按重量配比取阳桃、九节风、淫羊霍、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,得干膏粉F;
(6)取中间产品干膏粉F与适量辅料混匀,制粒,干燥,分装,得成品颗粒剂。
5.根据权利要求1和2所述的生发黑发的中药制剂的生产方法,其特征在于:所述的胶囊的生产步骤如下:
(1)按重量配比阳桃、九节风、淫羊霍、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品F与适量辅料混匀,制粒,装胶囊,铝箔包装,分装,得成品胶囊剂。
6.根据权利要求1和2所述的生发黑发的中药制剂的生产方法,其特征在于:所述的片剂的生产步骤如下:
(1)按重量配比取阳桃、九节风、淫羊霍、何首乌、甘草、胶股蓝、茯苓、红花和枸杞,加5-8倍量水煎煮两次,每次1-2小时,合并为A液;
(2) 将以上药液A液,加热浓缩,得浓缩液B;
(3) B冷却后,加3倍量体积浓度的75-95%乙醇水溶液,混匀,4℃至8℃冰箱或冰库内,静置16-24小时,过滤,去沉淀;
(4) 滤液回收乙醇,将上述滤液放在乙醇回收装置内,加热回收乙醇,回收乙醇后的药液,加热浓缩,挥发残留的少量乙醇,得药液C;
(5) 取C液浓缩,喷雾干燥,得干膏粉F;
(6)取中间产品干膏粉F与适量辅粒混合,制粒,压片,包装,得成品片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210453181.4A CN102908458B (zh) | 2012-11-13 | 2012-11-13 | 生发黑发的中药制剂及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210453181.4A CN102908458B (zh) | 2012-11-13 | 2012-11-13 | 生发黑发的中药制剂及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102908458A true CN102908458A (zh) | 2013-02-06 |
CN102908458B CN102908458B (zh) | 2014-11-05 |
Family
ID=47607191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210453181.4A Expired - Fee Related CN102908458B (zh) | 2012-11-13 | 2012-11-13 | 生发黑发的中药制剂及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102908458B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101239177A (zh) * | 2008-03-18 | 2008-08-13 | 北京中科雍和医药技术有限公司 | 一种治疗脱发病和生发黑发的中药组合物及其制法 |
CN102907625A (zh) * | 2011-08-02 | 2013-02-06 | 李严 | 一种生发盐水黑豆的制备方法 |
-
2012
- 2012-11-13 CN CN201210453181.4A patent/CN102908458B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101239177A (zh) * | 2008-03-18 | 2008-08-13 | 北京中科雍和医药技术有限公司 | 一种治疗脱发病和生发黑发的中药组合物及其制法 |
CN102907625A (zh) * | 2011-08-02 | 2013-02-06 | 李严 | 一种生发盐水黑豆的制备方法 |
Non-Patent Citations (1)
Title |
---|
吴滋气: "自拟生发汤治疗脱发验案三则", 《上海中医药杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN102908458B (zh) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101961464A (zh) | 一种治疗黄疸的中药组合物及其制备方法 | |
CN104586669A (zh) | 一种减肥外用霜 | |
CN105582511A (zh) | 一种生发中药组合物及其制备方法和应用 | |
CN103555530A (zh) | 百合保健药酒 | |
CN103747779A (zh) | 毛发促生剂及其制作方法 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN102366517A (zh) | 防治气血虚弱的中草药 | |
CN102178825B (zh) | 一种养生药物及其加工成药剂的方法 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN101912551B (zh) | 一种安胎中药组合物 | |
CN103330866A (zh) | 一种治疗糖尿病的中成药及其制作方法 | |
CN103083522B (zh) | 一种生发育发的中药组合物、制备方法及应用 | |
CN103520302A (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN102579814B (zh) | 一种治疗家禽链球菌病的中药组合物 | |
CN102908458B (zh) | 生发黑发的中药制剂及其生产方法 | |
CN102091254B (zh) | 一种用于面部整容后消肿的中药组合物及其制备方法 | |
CN101485875A (zh) | 一种防治脱发药物组方及其制备方法 | |
CN104906526A (zh) | 一种用于卵巢早衰的中药制剂及其制备方法 | |
CN104687137A (zh) | 一种鹿茸健脑安神汤料的配方及生产方法 | |
CN104116912A (zh) | 一种用于肿瘤患者放化疗后康复的中药组合物 | |
CN104027652A (zh) | 一种降血糖中药制剂及其制备方法 | |
CN101507797A (zh) | 一种治疗脱发的药酒 | |
CN105148164A (zh) | 一种家畜安胎补气中药 | |
CN104474514A (zh) | 一种用于小儿发烧的中成药物 | |
CN103230550B (zh) | 治疗猪大便不通的中药栓剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 546100 No.137, Chengbei Road, Wuxuan Town, Wuxuan County, Laibin City, Guangxi Zhuang Autonomous Region Patentee after: Li Jianmin Address before: 532300, 272, Minsheng street, Peach Town, Chongzuo, the Guangxi Zhuang Autonomous Region, Xinxian County Patentee before: Li Jianmin |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141105 |